Related Experiment Video
Updated: Sep 23, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Advances in medical and antibiotic management of infective endocarditis
B M Kubak1, A P Nimmagadda, C D Holt
1Department of Medicine, University of California Los Angeles School of Medicine, USA.
Abstract:
Infective endocarditis remains a serious medical problem despite advancements in laboratory detection, echocardiographic techniques, and newer antibiotic agents. This article summarizes the microbial agents in infective endocarditis, in addition to developments in medical and antibiotic management.
Insights
Infective endocarditis is a significant health issue. This review covers the causative microbes and advances in medical and antibiotic treatments for this condition.
Area of Science:
- Cardiology
- Infectious Diseases
- Microbiology
Background:
- Infective endocarditis (IE) persists as a critical clinical challenge.
- Despite progress in diagnostics and therapeutics, IE presents ongoing management difficulties.
Purpose of the Study:
- To review the spectrum of microbial pathogens implicated in infective endocarditis.
- To discuss current advancements in the medical and antibiotic management of IE.
Main Methods:
- Literature review of microbial agents in IE.
- Analysis of recent developments in IE treatment strategies.
Main Results:
- Identification of common and emerging microbial culprits in IE.
- Overview of updated antibiotic regimens and supportive medical care.
Conclusions:
- Effective management of IE requires understanding its diverse microbial etiology.
- Continued research into novel therapeutic approaches is essential for improving patient outcomes in infective endocarditis.
Related Concept Videos
Mitral Stenosis III: Medical Management
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis III: Medical Management

